# Early Detection of Pancreatic Adenocarcinoma (PDAC) Using a Panel of Biomarkers

> **NCT04449406** · — · ACTIVE_NOT_RECRUITING · sponsor: **Queen Mary University of London** · enrollment: 3500 (estimated)

## Conditions studied

- Pancreatic Ductal Adenocarcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04449406
- **Lead sponsor:** Queen Mary University of London
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-01-01
- **Primary completion:** 2026-08-31
- **Final completion:** 2026-08-31
- **Target enrollment:** 3500 (ESTIMATED)
- **Last updated:** 2026-04-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04449406

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04449406, "Early Detection of Pancreatic Adenocarcinoma (PDAC) Using a Panel of Biomarkers". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04449406. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*